A look at the cumulative effect of diagnostic steps for primary tumor identification in patients with head and neck squamous cell carcinoma of unknown primary.
Should the Contralateral Tonsil Be Removed in Cases of HPV-Positive Squamous Cell Carcinoma of the Tonsil?
The contralateral tonsil should routinely be removed in cases of suspected or known unilateral HPV+ TSCC.
Outcome of Perioperative Oxandrolone for Patients with Cachexia Related to Head and Neck Cancer
Perioperative administration of oxandrolone resulted in objective improvements in prealbumin levels and subjective improvements in surgical wounds.
PET/CT Alone Should Not Be Used to Exclude Tonsillar Cancer
This particular study showed that an SUVmax ratio between tonsils >1.6 (62% sensitive, 100% specific) is highly suspicious and warrants biopsy.
When Should a Level IIB Neck Dissection Be Performed In Treatment of Head and Neck Squamous Cell Carcinoma?
In elective neck dissections for most HNSCC primary sites, level IIB nodes can be left intact, thus minimizing risk of damage to the spinal accessory nerve.
A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
Experts at the AAO-HNS Annual Meeting in Atlanta discuss checkpoint inhibitor success and ways to overcome resistance.
Head and Neck Chemo Delays Over 14 Weeks Increase Risk of Death
A look at the impact of delays in postoperative head and neck (HN) chemoradiotherapy on survival rates.
Women With HPV-Positive OPSCC Have Improved Overall Survival Rates
Sex does not play a prognostic role in HPV-negative OPSCC, and there are no differences in prognosis by race among HPV-positive or HPV-negative patients.
Diagnosing and Treating Depression in Head and Neck Cancer Patients
Survivors of Head and Neck Cancer Can Experience Long-Lasting Cognitive Impairment
Head and neck cancer survivors have neurocognitive sequelae up to two years after definitive chemoradiotherapy or radiation treatment.
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 10
- Next Page »